Amplification of the MYCN oncogene, either as intra-chromosomal homogenously staining regions (HSRs) or as extrachromosomal double minutes (16), is seen in around 20% of all NB cases and is one of the strongest unfavorable prognostic markers (17). This evidence concerns the gene MYCN and neuroblastoma.